These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17983687

  • 1. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
    Starzec A, Ladam P, Vassy R, Badache S, Bouchemal N, Navaza A, du Penhoat CH, Perret GY.
    Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
    [Abstract] [Full Text] [Related]

  • 2. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 3. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M.
    J Control Release; 2006 Mar 10; 111(1-2):153-64. PubMed ID: 16423422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
    Cébe-Suarez S, Grünewald FS, Jaussi R, Li X, Claesson-Welsh L, Spillmann D, Mercer AA, Prota AE, Ballmer-Hofer K.
    FASEB J; 2008 Aug 10; 22(8):3078-86. PubMed ID: 18467594
    [Abstract] [Full Text] [Related]

  • 6. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
    Novoa A, Pellegrini-Moïse N, Bechet D, Barberi-Heyob M, Chapleur Y.
    Bioorg Med Chem; 2010 May 01; 18(9):3285-98. PubMed ID: 20363638
    [Abstract] [Full Text] [Related]

  • 7. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
    Kamarulzaman EE, Vanderesse R, Gazzali AM, Barberi-Heyob M, Boura C, Frochot C, Shawkataly O, Aubry A, Wahab HA.
    J Biomol Struct Dyn; 2017 Jan 01; 35(1):26-45. PubMed ID: 26766582
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.
    Tymecka D, Lipiński PFJ, Fedorczyk B, Puszko A, Wileńska B, Perret GY, Misicka A.
    Peptides; 2017 Aug 01; 94():25-32. PubMed ID: 28627371
    [Abstract] [Full Text] [Related]

  • 9. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.
    Jaalouk DE, Ozawa MG, Sun J, Lahdenranta J, Schlingemann RO, Pasqualini R, Arap W.
    Cancer Res; 2007 Oct 15; 67(20):9623-9. PubMed ID: 17942890
    [Abstract] [Full Text] [Related]

  • 10. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
    Starzec A, Miteva MA, Ladam P, Villoutreix BO, Perret GY.
    Bioorg Med Chem; 2014 Aug 01; 22(15):4042-8. PubMed ID: 24961874
    [Abstract] [Full Text] [Related]

  • 11. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
    Thomas N, Bechet D, Becuwe P, Tirand L, Vanderesse R, Frochot C, Guillemin F, Barberi-Heyob M.
    J Photochem Photobiol B; 2009 Aug 03; 96(2):101-8. PubMed ID: 19464192
    [Abstract] [Full Text] [Related]

  • 12. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
    Tirand L, Thomas N, Dodeller M, Dumas D, Frochot C, Maunit B, Guillemin F, Barberi-Heyob M.
    Drug Metab Dispos; 2007 May 03; 35(5):806-13. PubMed ID: 17283031
    [Abstract] [Full Text] [Related]

  • 13. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
    Hess AP, Schanz A, Baston-Buest DM, Hirchenhain J, Stoff-Khalili MA, Bielfeld P, Kruessel JS.
    J Reprod Immunol; 2009 Jan 03; 79(2):129-36. PubMed ID: 18996601
    [Abstract] [Full Text] [Related]

  • 14. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S, Mehta S, Haque I, Sengupta K, Dhar K, Kambhampati S, Van Veldhuizen PJ, Banerjee SK.
    Biochemistry; 2008 Mar 18; 47(11):3345-51. PubMed ID: 18284215
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.
    Grabowska K, Puszko AK, Lipiński PF, Laskowska AK, Wileńska B, Witkowska E, Perret GY, Misicka A.
    Bioorg Med Chem; 2017 Jan 15; 25(2):597-602. PubMed ID: 27889287
    [Abstract] [Full Text] [Related]

  • 16. Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors.
    Giordano RJ, Anobom CD, Cardó-Vila M, Kalil J, Valente AP, Pasqualini R, Almeida FC, Arap W.
    Chem Biol; 2005 Oct 15; 12(10):1075-83. PubMed ID: 16242650
    [Abstract] [Full Text] [Related]

  • 17. The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress.
    Wang J, Wang S, Li M, Wu D, Liu F, Yang R, Ji S, Ji A, Li Y.
    PLoS One; 2015 Oct 15; 10(11):e0142571. PubMed ID: 26554379
    [Abstract] [Full Text] [Related]

  • 18. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
    Cui Q, Sulea T, Schrag JD, Munger C, Hung MN, Naïm M, Cygler M, Purisima EO.
    J Mol Biol; 2008 Jun 13; 379(4):787-802. PubMed ID: 18479705
    [Abstract] [Full Text] [Related]

  • 19. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
    Geretti E, Shimizu A, Klagsbrun M.
    Angiogenesis; 2008 Jun 13; 11(1):31-9. PubMed ID: 18283547
    [Abstract] [Full Text] [Related]

  • 20. L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.
    Stoeck A, Schlich S, Issa Y, Gschwend V, Wenger T, Herr I, Marmé A, Bourbie S, Altevogt P, Gutwein P.
    Cancer Lett; 2006 Aug 08; 239(2):212-26. PubMed ID: 16377081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.